|
Dysregulated miR34a/diacylglycerol kinase ζ interaction enhances T-cell activation in acquired aplastic anemia
|
Dec 2016
|
Oncotarget
|
aplastic anemia
|
|
Early treatment initiation in lower-risk myelodysplastic syndromes produces an earlier and higher rate of transfusion independence
|
Aug 2017
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Eat and be healthy: nutritional status in myelodysplastic syndromes
|
Jul 2020
|
Leukemia & Lymphoma
|
myelodysplastic syndromes (MDS)
|
|
Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria
|
Sep 2015
|
N Engl J Med
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Eculizumab in the management of paroxysmal nocturnal hemoglobinuria: patient selection and special considerations
|
Aug 2016
|
Ther Clin Risk Manag
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Eculizumab treatment improved renal hemosiderosis in a patient with paroxysmal nocturnal hemoglobinuria
|
Nov 2016
|
Int J Hematol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Eculizumab treatment of paroxysmal nocturnal hemoglobinuria presenting as moyamoya syndrome in a 9-year-old male.
|
Jan 2012
|
Pediatr Blood Cancer
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Eculizumab: a guide to its use in paroxysmal nocturnal hemoglobinuria
|
Apr 2012
|
BioDrugs
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia
|
Mar 2017
|
Haematologica
|
aplastic anemia
|
|
Effect of erythropoiesis-stimulating agent policy decisions on off-label use in myelodysplastic syndromes
|
Nov 2014
|
Medicare Medicaid Res Rev
|
myelodysplastic syndromes (MDS)
|
